Sign in
Taking people in United StatesPhase 1/2

Self-Guided Mobile App for Adults With Binge Eating and Obesity

Tests a self-guided phone app called ChangeBite in adults with obesity and binge eating.

Key facts

Who runs it
Drexel University
Where
Philadelphia, United StatesSee the site
Trial code
Registry title
A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity
Status
Recruiting
Phase
Phase 1/2
People taking part
30 people, planned
Started
Feb 2025
Planned end
Dec 2025
Type of study
Interventional
Treatments tested
  • Digital
Record updated
17 February 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with obesity who have repeated binge eating episodes. They would test a self-guided mobile app called ChangeBite.

Age
18 to 70 years
Sex
Men and women can join.
Disease stage
At least 12 binge eating episodes (objective or subjective) in 3 months, and a BMI of 30 or higher.
Earlier treatment
People cannot join if they are already getting treatment for an eating disorder or weight loss treatment (behavioral or drug).

Main reasons for not taking part

  • Speaking, reading and writing English not fluently
  • Getting treatment for an eating disorder or for weight loss
  • Severe mental health problems that limit taking part, such as high risk of suicide, substance use disorder or active psychosis
  • Purging or laxative use 3 or more times a week, or other harmful behaviors, without a primary care provider saying remote treatment is safe
  • Being pregnant or planning pregnancy within the next year

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Are English speaking male or female
  • Are aged 18-70 years
  • Have recurrent objective or subjective binge eating episodes (≥12 episodes in 3 months)
  • Have BMI ≥30
  • Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
  • Are willing and able to complete enrollment procedures
  • Are able to understand the nature of the study and provide written informed consent

Who cannot take part

  • Are already receiving treatment for an eating disorder (e.g., research participants cannot be receiving concurrent eating disorder treatment from another provider)
  • Are receiving weight loss treatment (behavioral or pharmacological)
  • Are individuals who are not yet adults (infants, children, teenagers) Are currently taking any of these medications: Haldol, Loxitane, Mellaril, Moban, Navane, Prolixin, Serentil, Stelaxine, Trilafon, Thoraxine, Abilify, Clozaril, Geodon, Risperdal, Seroquel, Zyprexa
  • Have a mental handicap or are currently experiencing severe psychopathology that would limit their ability to engage in study (e.g., imminent or high risk for suicide, substance use disorder, active psychotic disorder,)
  • Are unwilling to receive medical clearance and/or medical monitoring as requested by the study to ensure they are medically safe to participate
  • Are unable to fluently speak, write and read English
  • Are purging and/or using laxatives 3 or more times per week and are not deemed safe for remote treatment by a primary care provider
  • Are exercising 2 or more hours a day on average, or engaging in significantly harmful compensatory behaviors (i.e., > 3x/week of self-induced vomiting or laxative use), and are not deemed safe for remote treatment by a primary care provider
  • Are fasting for 24 hours or more, > 3x times a week, and are not deemed safe for remote treatment by a primary care provider
  • Are pregnant or planning to become pregnant within the next year
  • Are adults unable to consent
  • Are prisoners

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where in United States

  • Drexel UniversityPhiladelphia, United StatesContact: Stephanie Dr. Manasse, PhDTaking people

About the trial

What the trial wants to find out

The proposed study is an open label, non randomized, waitlist controlled single group feasibility study of the feasibility and usability of a digital intervention (called ChangeBite) to be used by individuals with obesity and comorbid binge eating behavior. The proposed research will include approximately 30 participants. Participants will be recruited for this single group pilot trial using online advertising to attend a virtual screening session. Screened participants willing and eligible to participate, will receive informed consent and formally start ChangeBite. Participants will be instructed to engage with ChangeBite and attend follow up assessments on scheduled video calls. Feasibility and acceptability of implementation will be assessed by collecting data on recruitment, retention, usability and satisfaction. The research team will also collect assessment data from participants on feasibility, and usability. In addition to self report scales, semi-structured interviews will be completed with a trained research team member via video call and will be partially recorded. Assessments will be done at baseline, 12 weeks, and 24 weeks. Participants' app use frequency and duration will be tracked using software analytics. Participants' body weight will be captured weekly using a timestamped picture of their weight as it appears on their scale and Body Mass Index will be calculated with these data points.

The group in the trial

  • Self-Help Digital InterventionTreatment being tested

    All study participants will receive the digital intervention (ChangeBite). Therefore, this study has 1 arm.

    Treatment: Digital

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity
Plain-language title
Self-Guided Mobile App for Adults With Binge Eating and ObesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06817863, who can take part
Record updated
17 February 2025